Dmitry Balyasny’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Dmitry Balyasny's BMY Position: Q3 2026 in Review
Dmitry Balyasny increased its Bristol-Myers Squibb (BMY) stake by 11% in Q3 2026, buying an estimated $604K and bringing the position to 97,848 shares worth $6.11M. The position accounts for 0.01% of the portfolio, ranked #1330.
Dmitry Balyasny first reported a position in BMY in Q1 2015 and has held it in 41 quarters since. The position peaked at $100M in Q4 2016. 2,555 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Dmitry Balyasny held 97,848 shares of Bristol-Myers Squibb worth $6.11M as of Q3 2026.
- Dmitry Balyasny bought 9,560 Bristol-Myers Squibb shares in Q3 2026, an estimated $604K.
- Bristol-Myers Squibb made up 0.01% of Dmitry Balyasny's portfolio in Q3 2026, its #1330 holding.
- Dmitry Balyasny first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 41 quarters since.
- Dmitry Balyasny's Bristol-Myers Squibb position peaked at $100M in Q4 2016.
- 2,555 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.